Author: Site Editor Publish Time: 2026-10-12 Origin: Site
LONCOM, a China-based pharmaceutical company specializing in active pharmaceutical ingredients (APIs), finished dosage forms (FDFs), pharmaceutical research and development, and manufacturing, participated in CPHI Milan 2026 from October 6–8 in Milan, Italy. The exhibition provided an opportunity to connect with international pharmaceutical companies, distributors, procurement teams, and potential business partners to explore opportunities in pharmaceutical supply, development, manufacturing, and market expansion.
Through its integrated pharmaceutical capabilities and flexible collaboration models, LONCOM works with international partners to explore solutions tailored to product requirements, regulatory frameworks, and local market needs.
CPHI Milan 2026 brought together stakeholders across the pharmaceutical value chain, covering APIs, finished dosage forms, pharmaceutical development, and contract manufacturing.
During the exhibition, LONCOM engaged with industry partners from different countries and regions to discuss product sourcing, regulatory requirements, supply chain coordination, and potential development and manufacturing projects. These discussions helped identify areas of mutual interest and provided further insight into the needs of international pharmaceutical markets.
For pharmaceutical companies seeking reliable supply partners or development and manufacturing support, collaboration requires more than product availability. Product quality, technical capabilities, regulatory alignment, and long-term supply reliability are also important considerations.
LONCOM continues to engage with international partners to understand these requirements and explore commercially and technically appropriate cooperation opportunities.
LONCOM supports international pharmaceutical collaboration through three core areas of business:
1. Active Pharmaceutical Ingredient (API) Supply
LONCOM offers API supply opportunities for pharmaceutical companies seeking raw materials for pharmaceutical development and manufacturing. Depending on the product and target market, cooperation can be explored in conjunction with applicable registration requirements and the customer's downstream development or manufacturing plans.
2. Finished Dosage Form (FDF) Development and Manufacturing
LONCOM supports collaboration involving finished dosage forms, including product development and manufacturing. Potential projects can be assessed according to dosage form requirements, target markets, regulatory pathways, and the partner's commercialization strategy.
3. Pharmaceutical R&D and Manufacturing Services
LONCOM works with partners to explore pharmaceutical research and development, contract manufacturing, and project-based collaboration. Depending on project scope and technical feasibility, these services may support different stages of pharmaceutical development, technology transfer, and manufacturing preparation.
The suitability of each cooperation model depends on product-specific capabilities, available technical documentation, quality requirements, regulatory conditions, and the agreed project scope.
LONCOM explores several cooperation models to address the different needs of international pharmaceutical companies.
API-linked registration: Cooperation involving API supply and relevant registration documentation, subject to applicable regulatory requirements and product-specific arrangements.
Marketing Authorization Holder (MAH) partnerships: Collaboration on pharmaceutical product authorization and commercialization arrangements, depending on the applicable national regulatory framework and the responsibilities agreed by the parties.
Contract Research Organization (CRO) services: Pharmaceutical research and development support tailored to project requirements and agreed deliverables.
Contract Manufacturing Organization (CMO) services: Manufacturing collaboration based on product feasibility, technical requirements, quality agreements, and applicable regulatory standards.
For partners considering local manufacturing or market entry, these models can also be evaluated as part of a broader project strategy. The appropriate approach depends on the target country's regulatory requirements, the product's registration status, local manufacturing policies, and the partner's commercial objectives.
By evaluating each project individually, LONCOM aims to establish cooperation arrangements that align technical feasibility, regulatory compliance, and commercial priorities.
Entering a new pharmaceutical market requires coordination across product supply, regulatory affairs, development, manufacturing, and commercialization. International partners may therefore need different combinations of services rather than a single standardized solution.
LONCOM seeks to address these needs through discussions focused on project requirements, product suitability, technical documentation, manufacturing feasibility, and potential regulatory pathways. Where appropriate, partners can explore cooperation ranging from API supply to finished dosage form projects and contracted R&D or manufacturing services.
The objective is to build sustainable business relationships supported by clear project responsibilities, appropriate quality systems, reliable execution, and alignment with local regulatory requirements.
CPHI Milan 2026 marked another opportunity for LONCOM to strengthen international industry connections and explore new pharmaceutical business opportunities.
Following the exhibition, LONCOM will continue engaging with potential partners to assess product opportunities, discuss project feasibility, and develop cooperation opportunities across API supply, finished dosage forms, pharmaceutical R&D, and manufacturing services.
LONCOM thanks all customers and industry partners who met with the team during the exhibition. The company looks forward to continuing these discussions and building long-term partnerships that support pharmaceutical development, manufacturing, and access to quality medicines in international markets.
Interested in working with LONCOM? Contact our team to discuss API sourcing, finished dosage form opportunities, pharmaceutical R&D, or contract manufacturing projects for your target market.
